JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB182146

Anti-LDHD/DLD antibody [EPR15068(B)]

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal LDHD/DLD antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.

View Alternative Names

DLD, Lactate dehydrogenase D, LDHD

1 Images
Western blot - Anti-LDHD/DLD antibody [EPR15068(B)] (AB182146)
  • WB

Supplier Data

Western blot - Anti-LDHD/DLD antibody [EPR15068(B)] (AB182146)

All lanes:

Western blot - Anti-LDHD/DLD antibody [EPR15068(B)] (ab182146) at 1/2000 dilution

Lane 1:

Human fetal liver lysate at 20 µg

Lane 2:

Human fetal heart lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab136636'>ab136636</a>) at 1/500 dilution

Predicted band size: 55 kDa

Observed band size: 50 kDa

false

  • Carrier free

    Anti-LDHD/DLD antibody [EPR15068(B)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR15068(B)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The LDHD/DLD protein also known as D-lactate dehydrogenase and capable of forming a complex with DLD (dihydrolipoamide dehydrogenase) has a molecular mass approximately 60 kDa. It mainly functions as an enzyme responsible for catalyzing the conversion of D-lactate to pyruvate in the mitochondria. Expression of LDHD is primarily observed in metabolic tissues such as liver kidney and heart. This protein plays an important role in energy production and metabolism by contributing to cellular redox balance.
Biological function summary

LDHD/DLD has an essential role in the mitochondrial energy metabolism through its involvement in the D-lactate metabolism. While LDHD/DLD itself is not formally a part of the pyruvate dehydrogenase complex DLD present in the complex shares the enzymatic responsibility for electron transfer needed for efficient energy conversion. The enzymatic action of LDHD in concert with DLD maintains cellular energy balance and supports effective metabolic processes.

Pathways

Research has shown connections between LDHD/DLD activity and the pyruvate metabolism and glycolysis pathways. In these pathways LDHD/DLD helps in channeling D-lactate derived electrons into the electron transport chain facilitating energy production in the form of ATP. The interaction between LDHD and proteins like pyruvate dehydrogenase ties them to those pathways ensuring proper cellular respiration and metabolic regulation within cells that demand high energy.

LDHD/DLD has been linked to issues involving lactic acidosis and some metabolic syndromes. A dysfunction in the enzymatic activity of LDHD/DLD could lead to the accumulation of D-lactate contributing to lactic acidosis which disrupts normal pH balance. Disorders in metabolic pathways involving DLD and related proteins can also manifest in altered energy metabolism linking LDHD/DLD to conditions like mitochondrial disorders and some forms of diabetes. Understanding the enzymatic roles of LDHD/DLD helps in devising therapeutic approaches for these metabolic diseases.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Involved in D-lactate, but not L-lactate catabolic process.
See full target information LDHD
style
left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:10496 PubMed39627214

2024

ATAD5-BAZ1B interaction modulates PCNA ubiquitination during DNA repair.

Applications

Unspecified application

Species

Unspecified reactive species

Yeongjae Kim,Na Young Ha,Mi-Sun Kang,Eunjin Ryu,Geunil Yi,Juyeong Yoo,Nalae Kang,Byung-Gyu Kim,Kyungjae Myung,Sukhyun Kang

Oncology reports 44:293-302 PubMed32319665

2020

Role of glucose metabolism in the differential antileukemic effect of melatonin on wild‑type and FLT3‑ITD mutant cells.

Applications

Unspecified application

Species

Unspecified reactive species

Noelia Puente-Moncada,Maria Turos-Cabal,Ana M Sánchez-Sánchez,Isaac Antolín,Federico Herrera,Jezabel Rodriguez-Blanco,Cristina Duarte-Olivenza,Carmen Rodriguez,Vanesa Martín
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB110330

Anti-PDHA1 antibody [9H9AF5]

KO Validated

Western blot - Anti-PDHA1 antibody [9H9AF5] (AB110330)

  • 5
  • 8
Primary Antibodies

AB155996

Anti-PDHB antibody [EPR11097(B)]

BOND RX™ Validated|RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHB antibody [EPR11097(B)] (AB155996)

  • 0
  • 0
Primary Antibodies

AB222102

Anti-IL-4I1/LAO antibody [EPR22070]

RabMAb|Recombinant|20ul selling size

Immunocytochemistry/ Immunofluorescence - Anti-IL-4I1/LAO antibody [EPR22070] (AB222102)

  • 5
  • 4
Primary Antibodies

AB198005

Anti-DHRS3 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DHRS3 antibody (AB198005)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com